Search – Page 70 – Indianapolis Business Journal

Home » Search

Articles

Endocyte’s $2.1B deal with Novartis comes after years of setbacks

October 18, 2018 | John Russell

The West Lafayette biotech firm’s stock traded as low as $1.41 last fall, following multiple setbacks and restructurings. But the stock had soared to $24 Thursday morning after news that it would be acquired by Novartis.

DeHaan retiring as CEO of education not-for-profit she founded in 1998

October 17, 2018

A former Indianapolis mayor will succeed Christel DeHaan as CEO of Christel House International, an organization that operates nine schools in four countries.

U.S. wants drug prices in TV ads: ‘Patients deserve to know’

October 16, 2018

The drug industry's main trade group said drug companies are only willing to disclose the prices on their websites, not in commercials, and they'll start doing that next spring.

Elanco shares lowest since IPO after failing to get consensus buy rating

October 15, 2018

Shares in Elanco Animal Health Inc. slipped as much as 3.3 percent Monday morning after lead managers and other banks involved in its recent initial public offering started coverage on the animal health company.

BioCrossroads forms $9M seed fund for life science startups

October 11, 2018

The Indiana Seed Fund III is an early-stage fund focused on developing startups in life sciences, health IT and agricultural biosciences.

IU researcher wins $44.7M to study rare form of Alzheimer’s disease

October 4, 2018

The IU School of Medicine said the grant, its largest-ever National Institutes of Health award, will fund a five-year study of a form of Alzheimer’s disease that affects young people.

Lilly might market diabetes drug for obesity after research results

October 4, 2018

Eli Lilly and Co.’s stock jumped Thursday after midstage research on an experimental diabetes drug showed significant weight loss in patients. The news took a toll on shares of rival Novo Nordisk.

Records

October 4, 2018

Contracts Smart Guided Systems LLC has announced a licensing agreement with USDA Office of Technology Transfer to commercialize the Intelligent Spray Control System. Phone: 317-222-4152; E-mail: [email protected]. Fundraising Indianapolis Professional Association to benefit from “The Current State of the Local Minority Economy,” on Oct. 26 from 6-9 p.m. at The District Tap, 3720 E. 82nd […]

With $3 million in capital secured, Torchlite ignites growth plan

October 3, 2018

The Indy-based firm plans to accelerate marketing of its platform for finding and managing on-demand digital marketing talent as well as add employees and grow the firm’s footprint beyond the Midwest.

Big gymnasium in downtown corporate campus to be demolished

October 2, 2018 | Mason King

The owner of the 40,000-square-foot gym says upgrading the facility would cost tens of millions of dollars, and that the cost to maintain it is greater than the property’s value.

Migraine drug from Eli Lilly approved by FDA

September 28, 2018

Eli Lilly and Co. received clearance Thursday from U.S. regulators for a new migraine drug that will be the third in a promising class of therapies for patients who suffer from the recurrent, painful headaches.

The case for (and against) investing in Elanco Animal Health

September 26, 2018

Investors hope Greenfield-based Elanco—the No. 4 animal health company in the world—will be the next Zoetis, the former animal-health division of Pfizer, which has nearly tripled in value since going public in 2013.

Drew White: Ripe with potential, Cole-Noble needs a plan for its future

September 26, 2018

I think Cole-Noble should build upon its commercial history and become an innovation district. Startup companies (and even live-work communities) could provide research, consulting and financial services for corporate giants like Cummins and Eli Lilly and Co.

« Previous 1 … 68 69 70 71 72 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

Endocyte’s $2.1B deal with Novartis comes after years of setbacks

DeHaan retiring as CEO of education not-for-profit she founded in 1998

Elanco shares lowest since IPO after failing to get consensus buy rating

BioCrossroads forms $9M seed fund for life science startups

IU researcher wins $44.7M to study rare form of Alzheimer’s disease

Lilly might market diabetes drug for obesity after research results

Records

With $3 million in capital secured, Torchlite ignites growth plan

Big gymnasium in downtown corporate campus to be demolished

Migraine drug from Eli Lilly approved by FDA

The case for (and against) investing in Elanco Animal Health

Drew White: Ripe with potential, Cole-Noble needs a plan for its future

UPDATE: Elanco shares rise 50 percent in first day after $1.5B animal-health IPO

Lilly’s Elanco animal-health business raises $1.5 billion in IPO

Competitor beats Lilly to market with migraine drug approval

Deborah Daniels: Hate-crime law would help Hoosier employers thrive

GOP selects Jefferson Shreve to replace Jeff Miller on council

Lilly’s Elanco spinoff expected to raise up to $1.45 billion in IPO

Franklin College lands $2M gift from former Eli Lilly executive